search
Back to results

Research and Development of WPAPS Based on the Modern Technology of Traditional Chinese Medicine

Primary Purpose

Dysmenorrhea

Status
Recruiting
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Warm Palace Analgesic Point Sticker
Sponsored by
Hong Kong Baptist University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dysmenorrhea

Eligibility Criteria

18 Years - 35 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: (1)18-35 years old; (2) Have a regular history of the menstrual cycle (28 days ± 7 days); (3) The first dysmenorrhea occurs before the age of 25, and at least 2 cycles after menarche; (4) No pregnancy/abortion / ectopic pregnancy history before the first dysmenorrhea; (5) Moderate to severe menstrual pain experienced at least 3 menstrual cycles prior to enrollment; (6) TCM syndrome differentiation is Qi stagnation and blood stasis syndrome and cold dampness syndrome. Exclusion Criteria: Women with secondary dysmenorrhea (include but not limited to endometriosis, pelvic inflammation or hysteromyoma) confirmed by gynaecologists through B-mode ultrasound; (2) Women with irregular menstrual cycle (menstruation is advanced or delayed no more than 7 days); (3) women who are suffering from uncontrollable nervous system diseases, immune deficiency, haemorrhagic diseases or other serious chronic diseases; (4) women who have taken prostaglandin synthase inhibitor (PGSI) two weeks before enrolment; (5) women who are lactating, pregnant or planning to pregnant in the next 6 months; (6) women who are taking drugs that may affect the results of the study (include but not limited to NSAIDs and oral contraceptives); (7) Women who are receiving moxibustion or have received moxibustion 2 weeks before enrolment; (8) Women who are participating in other clinical studies; (9) Those who cannot cooperate with application treatment; (10) Have a history of severe skin allergy and are allergic to more than 2 kinds of food or drugs.

Sites / Locations

  • School of Chinese Medicine BuildingRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Warm Palace Analgesic Point Sticker Group

Control Group

Arm Description

Participants in the EG group will be provided test sticker, containing Ding Xiang, Rou Gui, Gan Jiang, Huang Jie Zi, Rou Cong Rong, Xiao Hui Xiang, Hua Jiao, Ai Ye, Xiang Fu, Wu Zhu Yu, Graphene(0.01%)The acupoints for applying the sticker are Guanyuan (CV4), Zigong (EX-CA1), and Sanyinjiao (SP6). The subjects will be reminded to closely observe their skin during the process and remove the sticker in time if the subjects feel itchy or painful, and record the adverse event.

Participants in the CG group will be provided control sticker containing flour.The acupoints for applying the sticker are the same with experimental group

Outcomes

Primary Outcome Measures

Change From Baseline in Scores on the Cox Menstrual Symptom Scale at 3 Months
This scale was developed by the University of Virginia to evaluate the severity and duration of dysmenorrhea symptoms. The scale includes 17 items, all of which adopt the 5-level scoring method, in which 0 is for not noticeable / did not occur, 1 is for slightly bothersome / lasted less than 3 hours, 2 is for moderate bothersome/lasting 3-7 hours, 3 is for severely bothersome / lasted 7-24 hours, and 4 is for very severely bothersome / lasted > 24 hours. The severity and duration of symptoms are scored separately, which can not only analyse the overall state but also study the state of each item. The higher the score, the more serious the condition is.

Secondary Outcome Measures

Numerical Rating Scale (NRS)
In a Numerical Rating Scale (NRS), patients are asked to select the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Beck Anxiety Inventory (BAI)
BAI measures anxiety severity through a self-statement manner. This scale contains 21 items with a four-point scoring method describing anxiety symptoms. On the scale, 0 is for "Not at All", 1 is for "Mildly but it did not bother me much", 2 is for "Moderately -it was not pleasant at times", and 3 is for "Severely - it bothered me a lot", to measure and infer the anxiety severity. Scores may range from 0 to 63 with 4 levels: minimal anxiety (0-7), mild anxiety (8-15), moderate anxiety (16-25), and severe anxiety (26-63).

Full Information

First Posted
March 20, 2023
Last Updated
April 4, 2023
Sponsor
Hong Kong Baptist University
Collaborators
Innovation and Technology Commission, Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT05815654
Brief Title
Research and Development of WPAPS Based on the Modern Technology of Traditional Chinese Medicine
Official Title
Research and Development of Warm Palace Analgesic Point Stickers Based on the Modern Technology of Traditional Chinese Medicine: Study Protocol for a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
December 20, 2022 (Actual)
Primary Completion Date
October 31, 2023 (Anticipated)
Study Completion Date
February 29, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hong Kong Baptist University
Collaborators
Innovation and Technology Commission, Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The goal of this double-blind randomized controlled trial is to determine the efficacy of Warm Palace Analgesic Point Sticker in relieving dysmenorrhea compared to placebo sticker. The main questions it aims to answer are: Can this Warm Palace Analgesic Point Sticker relieve dysmenorrhea? It is more effective to certain type of TCM syndrome differentiation? Qi stagnation and blood stasis syndrome or cold dampness syndrome? Participants will : receive test sticker or control sticker five days before every menstruation, once a day, five hours each time, for five consecutive days take pictures of tongue fill in some questionnaires after treatment
Detailed Description
This study aims to determine the efficacy of Warm Palace Analgesic Point Sticker in relieving dysmenorrhea compared to placebo sticker through a double-blind, randomized controlled trial. Two hundred participants will be enrolled. This trial consisting of an intervention phase for three menstrual cycles. After receiving an explanation of the trial and providing online informed consent, participants will be given screening numbers by registration order. Pain intensity of participants who completed the screening test will be assessed as baseline information during a run-in period. The run-in period will not exceed 40days. Before the run-in period, the participants will be offered an online diary and educated on how to record pain intensity using the Numerical Rating Scale (NRS) from one day before menstruation starts until menstruation ends. The participants will be forbidden to self-administer the medications presented in the exclusion or drop-out criteria. Participants with moderate or severe level of pain, average NRS pain scores greater than 4 on the first and second days of menstruation will be selected for enrollment in this trial, and the selected participants will receive randomly generated enrollment numbers. After the screening, the subjects will attend an online interview for evaluation, briefing, and tongue photo capturing and photo taking training. Then subjects will be randomly divided into two groups, the test sticker group, and the control sticker group. The total study period for each subject will be three months. Within three days from the end of the previous menstruation cycle, the participants will contact the research assistant, return their online diary, answer questionnaires regarding outcome measurements, and send back their tongue picture at each assessment. The intervention will be done during three menstrual cycles. One menstrual cycle may range from 21 to 40 days. We plan to conduct this trial for two years, starting from November 2022.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysmenorrhea

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
200 participants will be divided into experimental group and control group.
Masking
ParticipantInvestigator
Masking Description
Participants will be randomly assigned to the experimental group (EG), or the placebo control group (CG) at a ratio of 5:5 stratified by recruitment site. Stratified block randomization will be used according to probability theory. An independent statistician will generate random sequences using R software version 4.2.1 (R Project for Statistical Computing, Vienna, Austria), in which the TCM syndrome type, duration, and the severity of dysmenorrhea will be used as indicators, after a patient's qualification is confirmed, a randomization number and its corresponding sticker will be provided to the assistant by the PI. Then the assistant will give the specific sticker to the subjects to ensure that both the assistant and the subjects will not know which type of sticker they get.
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Warm Palace Analgesic Point Sticker Group
Arm Type
Experimental
Arm Description
Participants in the EG group will be provided test sticker, containing Ding Xiang, Rou Gui, Gan Jiang, Huang Jie Zi, Rou Cong Rong, Xiao Hui Xiang, Hua Jiao, Ai Ye, Xiang Fu, Wu Zhu Yu, Graphene(0.01%)The acupoints for applying the sticker are Guanyuan (CV4), Zigong (EX-CA1), and Sanyinjiao (SP6). The subjects will be reminded to closely observe their skin during the process and remove the sticker in time if the subjects feel itchy or painful, and record the adverse event.
Arm Title
Control Group
Arm Type
Placebo Comparator
Arm Description
Participants in the CG group will be provided control sticker containing flour.The acupoints for applying the sticker are the same with experimental group
Intervention Type
Device
Intervention Name(s)
Warm Palace Analgesic Point Sticker
Intervention Description
The Warm Palace Analgesic Point Sticker is developed by Changchun University of Traditional Chinese Medicine
Primary Outcome Measure Information:
Title
Change From Baseline in Scores on the Cox Menstrual Symptom Scale at 3 Months
Description
This scale was developed by the University of Virginia to evaluate the severity and duration of dysmenorrhea symptoms. The scale includes 17 items, all of which adopt the 5-level scoring method, in which 0 is for not noticeable / did not occur, 1 is for slightly bothersome / lasted less than 3 hours, 2 is for moderate bothersome/lasting 3-7 hours, 3 is for severely bothersome / lasted 7-24 hours, and 4 is for very severely bothersome / lasted > 24 hours. The severity and duration of symptoms are scored separately, which can not only analyse the overall state but also study the state of each item. The higher the score, the more serious the condition is.
Time Frame
through study completion, an average of 3 months
Secondary Outcome Measure Information:
Title
Numerical Rating Scale (NRS)
Description
In a Numerical Rating Scale (NRS), patients are asked to select the number between 0 and 10 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Time Frame
through study completion, an average of 3 months
Title
Beck Anxiety Inventory (BAI)
Description
BAI measures anxiety severity through a self-statement manner. This scale contains 21 items with a four-point scoring method describing anxiety symptoms. On the scale, 0 is for "Not at All", 1 is for "Mildly but it did not bother me much", 2 is for "Moderately -it was not pleasant at times", and 3 is for "Severely - it bothered me a lot", to measure and infer the anxiety severity. Scores may range from 0 to 63 with 4 levels: minimal anxiety (0-7), mild anxiety (8-15), moderate anxiety (16-25), and severe anxiety (26-63).
Time Frame
through study completion, an average of 3 months
Other Pre-specified Outcome Measures:
Title
TCM Body Constitution Scale Questionnaire
Description
We will use the questionnaire developed by Prof. Wang Qi, School of Traditional Chinese Medicine, BUCM, to diagnose body constitution of subjects. There are totally 60 questions describing symptom of 9 constitutions, and each symptom is scored via 1-5: a score of one denotes that the symptom is not noticeable; while a score of five denotes that the symptom is severely bothersome.A score higher than 40% means that the patient belongs to that constitution.
Time Frame
baseline, pre-intervention
Title
TCM Syndrome Type Questionnaire
Description
We will use a 16-item questionnaire to differentiate the type of dysmenorrhea. 16 questions describe symptoms of 5 syndrome type of dysmenorrhea, and each symptom is scored via 0-4: a score of zero denotes that the symptom is not noticeable; while a score of four denotes that the symptom is severely bothersome.A score higher than 75% means that the patient belongs to that syndrome type.
Time Frame
baseline, pre-intervention
Title
Tongue Image Features
Description
We will distinguish the color of tongue with a color board, which used for judgement of TCM body constitution and syndrome type of dysmenorrhea
Time Frame
through study completion, an average of 3 months

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Dysmenorrhea only occur to female.
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (1)18-35 years old; (2) Have a regular history of the menstrual cycle (28 days ± 7 days); (3) The first dysmenorrhea occurs before the age of 25, and at least 2 cycles after menarche; (4) No pregnancy/abortion / ectopic pregnancy history before the first dysmenorrhea; (5) Moderate to severe menstrual pain experienced at least 3 menstrual cycles prior to enrollment; (6) TCM syndrome differentiation is Qi stagnation and blood stasis syndrome and cold dampness syndrome. Exclusion Criteria: Women with secondary dysmenorrhea (include but not limited to endometriosis, pelvic inflammation or hysteromyoma) confirmed by gynaecologists through B-mode ultrasound; (2) Women with irregular menstrual cycle (menstruation is advanced or delayed no more than 7 days); (3) women who are suffering from uncontrollable nervous system diseases, immune deficiency, haemorrhagic diseases or other serious chronic diseases; (4) women who have taken prostaglandin synthase inhibitor (PGSI) two weeks before enrolment; (5) women who are lactating, pregnant or planning to pregnant in the next 6 months; (6) women who are taking drugs that may affect the results of the study (include but not limited to NSAIDs and oral contraceptives); (7) Women who are receiving moxibustion or have received moxibustion 2 weeks before enrolment; (8) Women who are participating in other clinical studies; (9) Those who cannot cooperate with application treatment; (10) Have a history of severe skin allergy and are allergic to more than 2 kinds of food or drugs.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Po Ching Au
Phone
68224897
Email
ching2022@hkbu.edu.hk
First Name & Middle Initial & Last Name or Official Title & Degree
Jing Ting Tian
Phone
54846560
Email
ayatian@hkbu.eu.hk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shi Ping Zhang
Organizational Affiliation
Hong Kong Baptist University
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Chinese Medicine Building
City
Kowloon Tong
State/Province
Kowloon
ZIP/Postal Code
0000
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Po Ching Au, Bachelor
Phone
8526822 4897
Email
ching2022@hkbu.edu.hk
First Name & Middle Initial & Last Name & Degree
Shi Ping Zhang, PhD
Phone
85234112466
Ext
2466
Email
spzhang@hkbu.edu.hk

12. IPD Sharing Statement

Learn more about this trial

Research and Development of WPAPS Based on the Modern Technology of Traditional Chinese Medicine

We'll reach out to this number within 24 hrs